{"id":"https://genegraph.clinicalgenome.org/r/083c3346-e480-4c29-86a2-272449c10b29v1.0","type":"EvidenceStrengthAssertion","dc:description":"The linkage region of SBF2 on chromosome 11p15 was first reported in 1999 in association with autosomal recessive CMT with focally-folded myelin (PMID: 10644431). In 2003, an in-frame deletion in SBF2 was described (PMID: 12554688), followed by several stop (e.g. 12687498, 15304601), frame-shift (PMID: 25873783, 30028002), and splice variants (PMID: 15477569) all representing biallelic loss-of-function changes. The mutation spectrum was later enlarged by missense variants as well (PMID: 30028002), likewise leading to a childhood-onset CMT phenotype with slow nerve conduction velocities (~ 15m/s) and tomaculous myelin outfoldings. The loss-of function pathomechanism is supported by a SBF2 knockout mouse model (PMID: 17855448, 18349142, 23297362) well-reproducing phenotypic elements such as muscle weakness, poor motor performance, reduced nerve conduction velocities and delayed F-waves, as well as myelin folding abnormalities. SBF2 is expressed in the Schwann cell cytoplasm (PMID: 23297362) and interacts with MTMR2 (15998640, 23297362), a protein that is likewise associated with AR demyelinating CMT (CMT4B1).\nIn summary, SBF2 is definitively associated with autosomal recessive demyelinating Charcot-Marie-Tooth disease. This has been repeatedly demonstrated in both research and clinical diagnostic settings, and has been upheld over time. ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/083c3346-e480-4c29-86a2-272449c10b29","GCISnapshot":"https://genegraph.clinicalgenome.org/r/01893bf4-e95d-4206-9d2e-e3822f778b7a","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/01893bf4-e95d-4206-9d2e-e3822f778b7a_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10063","date":"2021-03-22T20:13:23.585Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/01893bf4-e95d-4206-9d2e-e3822f778b7a_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10063","date":"2021-03-22T20:13:09.257Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01893bf4-e95d-4206-9d2e-e3822f778b7a_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01893bf4-e95d-4206-9d2e-e3822f778b7a_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/83b4b90c-9af3-49c1-a1b1-40d1adb6706c","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b87dc19-b28b-4fdd-a698-45162501e6af","type":"Finding","dc:description":"Phenotype fully reproduced","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18349142","rdfs:label":"SBF2-/- mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d7456b47-d767-4398-afe4-d0056c3748b8","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f72ad95-fab8-4066-9c89-7f56cbbb2752","type":"Finding","dc:description":"Phenotype is consistently reproduced","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17855448","rdfs:label":"SBF2-/- mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ce6fdc34-fb7e-4dbc-86fd-9de31d3a9373","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0c5a2a7-c0ca-4fff-8ccc-91cbc4bd9f61","type":"Finding","dc:description":"Phenotype reproduced, LOF is a shared mechanism","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31772832","rdfs:label":"GWAS in dog breeds with hereditary neuropathy","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/01893bf4-e95d-4206-9d2e-e3822f778b7a_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c7a0662-e291-4be0-9632-e489e7a5c202","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14533aa6-8eab-4ac0-8f5a-7c437f22ec16","type":"Finding","dc:description":"Both genes are involved in myelination regulation, interaction shown here","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15998640","rdfs:label":"Co-immunoprecipitation","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d5e3378b-3eb2-4626-b825-dc68ab1a9c10","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce58dca4-8efd-4241-b55b-c06af10ecafe","type":"Finding","dc:description":"Cross-sections of sciatic nerves from 8- or 9-month-old mice examined by immunofluorescence microscopy:\nAnti-Mtmr13 immunofluorescence (green) is detected in the Schwann cell cytoplasm and the axon, but is excluded from compact myelin and the Schwann cell nucleus\nPunctate Mtmr13-positive structures are detected in the Schwann cell cytoplasm\nAnti-Mtmr13 immunofluorescence (green) is greatly reduced in an Mtmr13-/- nerve section\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23297362","rdfs:label":"Immunofluorescence microscopy","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5},{"id":"https://genegraph.clinicalgenome.org/r/01893bf4-e95d-4206-9d2e-e3822f778b7a_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84d990ee-76fb-4e5b-8c31-3d64e1780410_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Homozygous stop mutation with LOF as the confirmed pathomechanism associated with SBF2","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94a64d76-6be0-456b-808f-521c0f8aa13f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12687498","rdfs:label":"IV.10","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":8,"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0003431","obo:HP_0002936","obo:HP_0003481","obo:HP_0000501","obo:HP_0002460"],"previousTesting":true,"previousTestingDescription":"CMT loci: 17p11.2 (CMT1A [MIM 118220]) (Timmerman et al. 1990), 1q22-23 (CMT1B [MIM 118200], the MPZ gene [MIM 159440]) (Hayasaka et al. 1993), 10q23 (EGR2) (Warner et al. 1998), 5q23-q33 (CMT4C) (LeGuern et al. 1996), 8q13-q21 (the CMT4A locus, GDAP1) (Ben Othmane et al. 1993), 8q24 (the HMSNL locus, NDRG1 [MIM 605262]) (Kalaydjieva et al. 1996), 11q23 (the CMT4B1 locus, MTMR2) (Bolino et al. 1996); the POAG loci are 1q23-q25 (GLC1A) (Richards et al. 1994), 2cen-q13 (GLC1B [MIM 606669]) (Stoilova et al. 1996), 3q21-q24 (GLC1C [MIM 606669]) (Wirtz et al. 1997), 6p25 (IRID1) (Jordan et al. 1997), 8q23 (GLC1D [MIM 602429]) (Trifan et al. 1998), 10p15-p14 (GLC1E [MIM 137760]) (Sarfarazi et al. 1998), 7q35-q36 (GLC1F [MIM 603383]) (Wirtz et al. 1999), 2p21 (GLC3A [MIM 231300]) (Sarfarazi et al. 1995), and 1p36 (GLC3B [MIM 600975]) (Akarsu et al. 1996). PCRs were performed according to published procedures. The PCR products were pooled, combined with the GeneScan HD Rox 400 size standard, loaded onto a 4.8% PAGE-plus, and run on the ABI PRISM 377 DNA Sequencer (PerkinElmer/Applied Biosystems)","secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/84d990ee-76fb-4e5b-8c31-3d64e1780410_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12687498","allele":{"id":"https://genegraph.clinicalgenome.org/r/0dc10a36-1f6f-4f91-8d72-0e232989dcad","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030962.3(SBF2):c.2875C>T (p.Gln959Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115862"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0effcd91-998c-4e95-b052-c8304113afae_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Homozygous frameshift mutation with predicted LOF, LOF is the associated pathomechanism for SBF2","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c62d67a-005d-4a1c-a24e-85af4a7b4948","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25873783","rdfs:label":"III.1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"Difficulty walking, Hyporeflexia, Foot dorsiflexor weakness, \nPes cavus, Distal muscle weakness, \nDistal amyotrophy, Decreased motor nerve conduction velocity, \nSteppage gait, Poor fine motor coordination, Sensory ataxia, Glaucoma\n","phenotypes":["obo:HP_0003376","obo:HP_0003431","obo:HP_0009027","obo:HP_0001761","obo:HP_0002460","obo:HP_0010871","obo:HP_0001265","obo:HP_0002355","obo:HP_0003693","obo:HP_0000501","obo:HP_0007010"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0effcd91-998c-4e95-b052-c8304113afae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25873783","allele":{"id":"https://genegraph.clinicalgenome.org/r/851fe6ae-3d12-4fea-8609-8016acafc426","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000011.10:g.9785282_9785283del (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139768515"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f1274fa3-6cbb-4806-8aaf-17b6c5b60bc2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Homozygous stop mutation with LOF as the proven disease mechanism for SBF2, highly specific phenotype (demyelinating CMT + glaucoma)","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ef2c41b-4722-49ff-9ba0-00499c5c119f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15304601","rdfs:label":"V.1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":13,"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Hyporeflexia, Pes cavus, Distal muscle weakness, \nDistal amyotrophy, Decreased motor nerve conduction velocity, \nDecreased number of peripheral myelinated nerve fibers, Glaucoma\n","phenotypes":["obo:HP_0003431","obo:HP_0003380","obo:HP_0000501","obo:HP_0001265","obo:HP_0001761","obo:HP_0002460","obo:HP_0003693"],"previousTesting":true,"previousTestingDescription":"PMP22, MPZ, GJB1, EGR2, NEFL, MTMR2, GDAP1, and PRX","secondTestingMethod":"Linkage analysis","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f1274fa3-6cbb-4806-8aaf-17b6c5b60bc2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15304601","allele":{"id":"https://genegraph.clinicalgenome.org/r/3bcc2880-ff9b-441e-a5ec-22a4995a5a53","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030962.3(SBF2):c.1459C>T (p.Arg487Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115868"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b06c75fc-f325-47c2-9293-71d1095479e5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Predicted null (splice) variant with LOF as the known pathomechanism associated with SBF2","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82eca80e-f9c1-414e-b2e6-391769cb66e9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15477569","rdfs:label":"II.3","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","phenotypeFreeText":"Difficulty walking, Hyporeflexia, Foot dorsiflexor weakness, \nPes cavus, Distal muscle weakness, \nDistal amyotrophy, Decreased motor nerve conduction velocity, \nDecreased number of peripheral myelinated nerve fibers, \nSteppage gait, Poor fine motor coordination, Sensory ataxia\n","phenotypes":["obo:HP_0003693","obo:HP_0002460","obo:HP_0007010","obo:HP_0003376","obo:HP_0003380","obo:HP_0010871","obo:HP_0003431","obo:HP_0009027","obo:HP_0002355","obo:HP_0001761","obo:HP_0001265"],"previousTesting":true,"previousTestingDescription":"microsatellite markers from the regions where unidentified CMT genes have been localized: llq.23 (CMT~BI,\" 8q.13 (CMT4AI.' 5q23 (CMT4C!.-j lp35-p36 ICMT~A,,: 3q13-q22 (CMT2B),\" and 7p14 (CMTZD 1.\" Moreover, to reveal partial duplication of 17~11.2, a Southern blot hybridization analysis of Msp I-digested DNA was performed using the polymorphic markers pVAW409R3a (D17S1221 and pEW401HE tD17S61).'\" The authors also examined the DNA for mutations of connexin (Cx)32, the four exons of the peripheral myelin protein 22 iPMP-22) (17~11.2) and the six exons of the protein zero (Po) (lq21-q25) genes.","secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/b06c75fc-f325-47c2-9293-71d1095479e5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15477569","allele":{"id":"https://genegraph.clinicalgenome.org/r/6566870a-dd06-4447-aa02-3124fcfb3f4d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030962.3(SBF2):c.4443+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/566898"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d1035e30-20a3-4fb2-87ee-2b6a157ee89d_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Both variants are predicted null variants, LOF is the known pathomechanism for this gene, both variants have very low allele frequencies in GnomAD, all other known CMT loci have been screened","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc9b4a52-3e07-45c5-9f44-feb9e017a412","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30028002","rdfs:label":"II.1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":6,"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0001171","obo:HP_0003380","obo:HP_0003431","obo:HP_0009027","obo:HP_0001265","obo:HP_0007010","obo:HP_0010871","obo:HP_0002460","obo:HP_0003693","obo:HP_0003376","obo:HP_0002355","obo:HP_0001761"],"previousTesting":true,"previousTestingDescription":"Linkage analysis, homozygosity mapping: CMT4A (GDAP1), CMT4B1 (MTMR2), CMT4B2 (SBF2), CMT4B3 (SBF1), CMT4C (SH3TC2), CMT4E (EGR2), CMT4F (PRX), CMT4H (FGD4), CMT4J (FIG4), HMSNL (NDRG1), HMSNR (HK1), AR-CMT2A (LMNA), AR-CMT2A2B (MFN2), AR-CMT2E (NEFL), AR-CMT2F (HSPB1), AR-CMT2P (LRSAM1), AR-CMT2R (TRIM2), AR-CMT2S (IGHMBP2), AR-CMT2T (MME), AR-CMT2 5q31 (HINT1), AR-CMT2 2q35 (HSJ1), AR-CMT2 13q12 (SACS), CMT RIC (PLEKHG5)\n\n","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d1035e30-20a3-4fb2-87ee-2b6a157ee89d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30028002","allele":[{"id":"https://genegraph.clinicalgenome.org/r/9840c818-8710-4af8-9177-d4270e8597a8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030962.3(SBF2):c.2578C>T (p.Arg860Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/546660"}},{"id":"https://genegraph.clinicalgenome.org/r/befd16c5-ac59-472c-8626-95abff6f8f49","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030962.3(SBF2):c.2597del (p.Pro866fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/546659"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/01893bf4-e95d-4206-9d2e-e3822f778b7a_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/06656dae-54fc-4b18-9e78-b2e3a71e14a6_family_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30028002","rdfs:label":"Lassuthova family D","family":{"id":"https://genegraph.clinicalgenome.org/r/06656dae-54fc-4b18-9e78-b2e3a71e14a6","type":"Family","rdfs:label":"Lassuthova family D","ethnicity":{"id":"cg:NotHispanicOrLatino"}},"phenotypePositiveAllelePositive":1},{"id":"https://genegraph.clinicalgenome.org/r/76b570e0-0e6c-40bf-9c29-8a52b8056315_family_segregation","type":"FamilyCosegregation","dc:description":"Two affected individuals only","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30028002","rdfs:label":"Lassuthova family A","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/76b570e0-0e6c-40bf-9c29-8a52b8056315","type":"Family","rdfs:label":"Lassuthova family A","ethnicity":{"id":"cg:NotHispanicOrLatino"}},"meetsInclusionCriteria":false,"phenotype":[{"id":"obo:HP_0001265"},{"id":"obo:HP_0010871"},{"id":"obo:HP_0002355"},{"id":"obo:HP_0003380"},{"id":"obo:HP_0003376"},{"id":"obo:HP_0003693"},{"id":"obo:HP_0009027"},{"id":"obo:HP_0007010"},{"id":"obo:HP_0001761"},{"id":"obo:HP_0002460"},{"id":"obo:HP_0000501"},{"id":"obo:HP_0003431"},{"id":"obo:HP_0002650"},{"id":"obo:HP_0001171"}],"phenotypeFreeText":"Difficulty walking, Hyporeflexia, Foot dorsiflexor weakness, \nPes cavus, Distal muscle weakness, \nDistal amyotrophy, Decreased motor nerve conduction velocity, \nDecreased number of peripheral myelinated nerve fibers, \nSteppage gait, Poor fine motor coordination, Sensory ataxia, Distal Sensory Deficits, Split Hand, Glaucoma, Scoliosis\n","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2},{"id":"https://genegraph.clinicalgenome.org/r/3d13f927-0c98-42e4-9144-27b9f9bf9bfd_proband_segregation","type":"FamilyCosegregation","dc:description":"Only two affected individuals that were tested available","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25873783","rdfs:label":"Negrao family 1","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/3d13f927-0c98-42e4-9144-27b9f9bf9bfd","type":"Family","rdfs:label":"Negrao family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9c62d67a-005d-4a1c-a24e-85af4a7b4948"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Difficulty walking, Hyporeflexia, Foot dorsiflexor weakness, \nPes cavus, Distal muscle weakness, \nDistal amyotrophy, Decreased motor nerve conduction velocity, \nSteppage gait, Poor fine motor coordination, Sensory ataxia, Glaucoma\n","phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001265","obo:HP_0000501","obo:HP_0002355","obo:HP_0001761","obo:HP_0007010","obo:HP_0002460","obo:HP_0003431","obo:HP_0009027","obo:HP_0003693","obo:HP_0003376","obo:HP_0010871"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9c62d67a-005d-4a1c-a24e-85af4a7b4948"}},{"id":"https://genegraph.clinicalgenome.org/r/13233a50-c6e3-47a6-83f4-64157b388709_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12687498","rdfs:label":"RBT-HAD","estimatedLodScore":1.33,"family":{"id":"https://genegraph.clinicalgenome.org/r/13233a50-c6e3-47a6-83f4-64157b388709","type":"Family","rdfs:label":"RBT-HAD","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/94a64d76-6be0-456b-808f-521c0f8aa13f"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0003431","obo:HP_0002936","obo:HP_0000501","obo:HP_0003481","obo:HP_0002460"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/94a64d76-6be0-456b-808f-521c0f8aa13f"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/d8ff758d-33ae-4c28-88f7-ac57ad432cbe_proband_segregation","type":"FamilyCosegregation","dc:description":"Two affected individuals only.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15477569","rdfs:label":"Conforti family 1","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/d8ff758d-33ae-4c28-88f7-ac57ad432cbe","type":"Family","rdfs:label":"Conforti family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/82eca80e-f9c1-414e-b2e6-391769cb66e9"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Difficulty walking, Hyporeflexia, Foot dorsiflexor weakness, \nPes cavus, Distal muscle weakness, \nDistal amyotrophy, Decreased motor nerve conduction velocity, \nDecreased number of peripheral myelinated nerve fibers, \nSteppage gait, Poor fine motor coordination, Sensory ataxia\n","phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0003376","obo:HP_0007010","obo:HP_0001761","obo:HP_0003431","obo:HP_0002460","obo:HP_0009027","obo:HP_0002355","obo:HP_0003693","obo:HP_0003380","obo:HP_0010871","obo:HP_0001265"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/82eca80e-f9c1-414e-b2e6-391769cb66e9"}},{"id":"https://genegraph.clinicalgenome.org/r/e21c656e-dfa0-48f9-b290-2405db7c83bb_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12687498","rdfs:label":"TUN-RE","estimatedLodScore":2.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/e21c656e-dfa0-48f9-b290-2405db7c83bb","type":"Family","rdfs:label":"TUN-RE","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/e1a70888-88a6-4cd3-85d9-e8de6ea545b7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12687498","rdfs:label":"V.1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":8,"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","previousTesting":true,"previousTestingDescription":"CMT loci: 17p11.2 (CMT1A [MIM 118220]) (Timmerman et al. 1990), 1q22-23 (CMT1B [MIM 118200], the MPZ gene [MIM 159440]) (Hayasaka et al. 1993), 10q23 (EGR2) (Warner et al. 1998), 5q23-q33 (CMT4C) (LeGuern et al. 1996), 8q13-q21 (the CMT4A locus, GDAP1) (Ben Othmane et al. 1993), 8q24 (the HMSNL locus, NDRG1 [MIM 605262]) (Kalaydjieva et al. 1996), 11q23 (the CMT4B1 locus, MTMR2) (Bolino et al. 1996); the POAG loci are 1q23-q25 (GLC1A) (Richards et al. 1994), 2cen-q13 (GLC1B [MIM 606669]) (Stoilova et al. 1996), 3q21-q24 (GLC1C [MIM 606669]) (Wirtz et al. 1997), 6p25 (IRID1) (Jordan et al. 1997), 8q23 (GLC1D [MIM 602429]) (Trifan et al. 1998), 10p15-p14 (GLC1E [MIM 137760]) (Sarfarazi et al. 1998), 7q35-q36 (GLC1F [MIM 603383]) (Wirtz et al. 1999), 2p21 (GLC3A [MIM 231300]) (Sarfarazi et al. 1995), and 1p36 (GLC3B [MIM 600975]) (Akarsu et al. 1996). PCRs were performed according to published procedures. The PCR products were pooled, combined with the GeneScan HD Rox 400 size standard, loaded onto a 4.8% PAGE-plus, and run on the ABI PRISM 377 DNA Sequencer (PerkinElmer/Applied Biosystems)","secondTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2a37be9c-f990-41ee-b93e-9aa70658a41c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12687498","allele":{"id":"https://genegraph.clinicalgenome.org/r/cd2cca93-106a-43a8-bd69-61a55d7eca72","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030962.3(SBF2):c.3586C>T (p.Arg1196Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115865"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"none"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Distal muscle weakness, Glaucoma, Distal sensory impairment, \nDecreased motor nerve conduction velocity, Segmental peripheral demyelination/remyelination\n","phenotypeNegativeAlleleNegative":8,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0000501","obo:HP_0003481","obo:HP_0002460","obo:HP_0002936","obo:HP_0003431"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/e1a70888-88a6-4cd3-85d9-e8de6ea545b7"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/764383e4-172f-4860-8474-aeca93a20082_family_segregation","type":"FamilyCosegregation","dc:description":"One tested individual only.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30028002","rdfs:label":"Lassuthova family D","family":{"id":"https://genegraph.clinicalgenome.org/r/764383e4-172f-4860-8474-aeca93a20082","type":"Family","rdfs:label":"Lassuthova family D"},"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":1},{"id":"https://genegraph.clinicalgenome.org/r/00be5583-88bf-4b4a-9380-d078f57fd243_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15304601","rdfs:label":"Hirano family 1","estimatedLodScore":1.58,"family":{"id":"https://genegraph.clinicalgenome.org/r/00be5583-88bf-4b4a-9380-d078f57fd243","type":"Family","rdfs:label":"Hirano family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9ef2c41b-4722-49ff-9ba0-00499c5c119f"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"Hyporeflexia, Pes cavus, Distal muscle weakness, \nDistal amyotrophy, Decreased motor nerve conduction velocity, \nDecreased number of peripheral myelinated nerve fibers, Glaucoma\n","phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0003380","obo:HP_0003431","obo:HP_0003693","obo:HP_0001265","obo:HP_0002460","obo:HP_0001761","obo:HP_0000501"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/9ef2c41b-4722-49ff-9ba0-00499c5c119f"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/b8bfeea2-236c-4099-ba84-c0403f28e271_proband_segregation","type":"FamilyCosegregation","dc:description":"Two affected individuals only","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30028002","rdfs:label":"Lassuthova family B","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/b8bfeea2-236c-4099-ba84-c0403f28e271","type":"Family","rdfs:label":"Lassuthova family B","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/dc9b4a52-3e07-45c5-9f44-feb9e017a412"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/dc9b4a52-3e07-45c5-9f44-feb9e017a412"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2a37be9c-f990-41ee-b93e-9aa70658a41c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Predicted stop mutation, and LOF is the confirmed pathomechanism associated with SBF2","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e1a70888-88a6-4cd3-85d9-e8de6ea545b7"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":2437,"specifiedBy":"GeneValidityCriteria8","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/CYhuxAlEuws","type":"GeneValidityProposition","disease":"obo:MONDO_0011475","gene":"hgnc:2135","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_01893bf4-e95d-4206-9d2e-e3822f778b7a-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}